These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 38966970)

  • 1. [Recent advances in protein precipitation-based methods for drug-target screening].
    Liu T; Qin WJ; Yang HJ
    Se Pu; 2024 Jul; 42(7):613-622. PubMed ID: 38966970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Target identification of natural and traditional medicines with quantitative chemical proteomics approaches.
    Wang J; Gao L; Lee YM; Kalesh KA; Ong YS; Lim J; Jee JE; Sun H; Lee SS; Hua ZC; Lin Q
    Pharmacol Ther; 2016 Jun; 162():10-22. PubMed ID: 26808165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Label-free target protein characterization for small molecule drugs: recent advances in methods and applications.
    Feng F; Zhang W; Chai Y; Guo D; Chen X
    J Pharm Biomed Anal; 2023 Jan; 223():115107. PubMed ID: 36334421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solvent-induced proteome profiling for proteomic quantitation and target discovery of small molecular drugs.
    Yu C; Chen X; Xu W; Li S; Chai Q; Zhang Y
    Proteomics; 2023 Jun; 23(12):e2200281. PubMed ID: 36843329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Target identification with quantitative activity based protein profiling (ABPP).
    Chen X; Wong YK; Wang J; Zhang J; Lee YM; Shen HM; Lin Q; Hua ZC
    Proteomics; 2017 Feb; 17(3-4):. PubMed ID: 27723264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Advances in applications of activity-based chemical probes in the characterization of amino acid reactivities].
    Li J; Wang G; Ye M; Qin H
    Se Pu; 2023 Jan; 41(1):14-23. PubMed ID: 36633073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solvent-Induced Protein Precipitation for Drug Target Discovery on the Proteomic Scale.
    Zhang X; Wang Q; Li Y; Ruan C; Wang S; Hu L; Ye M
    Anal Chem; 2020 Jan; 92(1):1363-1371. PubMed ID: 31794197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solvent-Induced Protein Precipitation for Drug Target Discovery.
    Zhang X; Hu L; Ye M
    Methods Mol Biol; 2023; 2554():35-45. PubMed ID: 36178619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability-based approaches in chemoproteomics.
    George AL; Dueñas ME; Marín-Rubio JL; Trost M
    Expert Rev Mol Med; 2024 Apr; 26():e6. PubMed ID: 38604802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of protein binding partners of small molecules using label-free methods.
    Saxena C
    Expert Opin Drug Discov; 2016 Oct; 11(10):1017-25. PubMed ID: 27554241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing target engagement using proteome-wide solvent shift assays.
    Van Vranken JG; Li J; Mitchell DC; Navarrete-Perea J; Gygi SP
    Elife; 2021 Dec; 10():. PubMed ID: 34878405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A brief introduction to chemical proteomics for target deconvolution.
    Dong ZC; Wang Y; Yang F; Wan F
    Eur Rev Med Pharmacol Sci; 2022 Sep; 26(17):6014-6026. PubMed ID: 36111901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass spectrometry approaches to monitor protein-drug interactions.
    Zinn N; Hopf C; Drewes G; Bantscheff M
    Methods; 2012 Aug; 57(4):430-40. PubMed ID: 22687620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small Molecule Interactome Mapping by Photo-Affinity Labeling (SIM-PAL) to Identify Binding Sites of Small Molecules on a Proteome-Wide Scale.
    Flaxman HA; Miyamoto DK; Woo CM
    Curr Protoc Chem Biol; 2019 Dec; 11(4):e75. PubMed ID: 31763793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of molecular targets of natural products by mass spectrometry.
    Cheng KW; Wong CC; Wang M; He QY; Chen F
    Mass Spectrom Rev; 2010; 29(1):126-55. PubMed ID: 19319922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in proteome-wide label-free target deconvolution for bioactive small molecules.
    Sun J; Prabhu N; Tang J; Yang F; Jia L; Guo J; Xiao K; Tam WL; Nordlund P; Dai L
    Med Res Rev; 2021 Nov; 41(6):2893-2926. PubMed ID: 33533067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical proteomics: terra incognita for novel drug target profiling.
    Huang F; Zhang B; Zhou S; Zhao X; Bian C; Wei Y
    Chin J Cancer; 2012 Nov; 31(11):507-18. PubMed ID: 22640626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profiling the Protein Targets of Unmodified Bio-Active Molecules with Drug Affinity Responsive Target Stability and Liquid Chromatography/Tandem Mass Spectrometry.
    Hwang HY; Kim TY; Szász MA; Dome B; Malm J; Marko-Varga G; Kwon HJ
    Proteomics; 2020 May; 20(9):e1900325. PubMed ID: 31926115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug Target Identification Using an iTRAQ-Based Quantitative Chemical Proteomics Approach-Based on a Target Profiling Study of Andrographolide.
    Wang J; Wong YK; Zhang J; Lee YM; Hua ZC; Shen HM; Lin Q
    Methods Enzymol; 2017; 586():291-309. PubMed ID: 28137568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical proteomics and its impact on the drug discovery process.
    Miao Q; Zhang CC; Kast J
    Expert Rev Proteomics; 2012 Jun; 9(3):281-91. PubMed ID: 22809207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.